Goldman Sachs Group Inc vs 22nd Century Group Inc — how do they compare? Goldman Sachs Group Inc trades at $1,096.32 (market cap $339.87B), while 22nd Century Group Inc trades at $4.33 (market cap $1.52M). The key difference: Goldman Sachs Group Inc is far larger — about 223598.7× 22nd Century Group Inc's market cap, and Goldman Sachs Group Inc pays a 1.56% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals.
| GS | XXII | |
|---|---|---|
Market Cap | $339.87B | $1.52M |
Volume | 2,592,735 | — |
Sector | Financials | Technology |
52-Week High | $1.15K | $1.47K |
52-Week Low | $700.41 | $3.90 |
Dividend Yield | 1.56% | — |
Enterprise Value | — | -$6.71M |
Signals from Pluang's Aura AI — not financial advice
Goldman Sachs (GS) trades at $1,140, up 9.0% over 24 hours, with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with Q2 2026 EPS beating expectations at $20.98 versus $14.47, and revenue growth from $58.28B in 2025 to $60.4B projected for 2026. Recent news highlights Goldman's role in leading high-profile IPOs including Anthropic, signaling strong investment banking pipeline strength.
Outlook remains positive with analyst consensus price target of $1,140K and 40% buy ratings, though RSI levels suggest potential near-term overbought conditions. Key risks include volatile cash flow patterns and high leverage, while institutional sentiment supports continued growth from M&A activity and AI-driven market opportunities.
22nd Century Group (XXII) trades at $4.33, up 3.34% on the day, following a recent 20:1 reverse stock split. The stock shows a bearish technical signal with support at $4 and resistance at $5. Fundamentally, the company continues to operate at a loss with negative gross and net profit margins, though revenue reached $7.05M in 2025. Recent news highlights aggressive expansion of its VLN reduced-nicotine cigarette brand into California and New York markets.
The outlook remains speculative with significant execution risk. While analyst consensus is strongly bullish (75% buy ratings), the company must demonstrate a path to profitability through its VLN product expansion. Key risks include persistent cash burn, competitive tobacco market pressures, and regulatory uncertainty. The stock represents a high-risk, high-potential turnaround play dependent on commercial success of its reduced-nicotine platform.
Trailing returns across standard periods
Latest headlines on both assets
The Goldman Sachs Group, Inc., a bank holding company, is a global investment banking and securities firm specializing in investment banking, trading and principal investments, asset management and securities services. The Company provides services to corporations, financial institutions, governments, and high-net worth individuals.
Read more on GS →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →